miRNA-302b suppresses human hepatocellular carcinoma by targeting AKT2.
Wang L, Yao J, Zhang X, Guo B, Le X, Cubberly M, Li Z, Nan K, Song T, Huang C.
Wang L, et al. Among authors: huang c.
Mol Cancer Res. 2014 Feb;12(2):190-202. doi: 10.1158/1541-7786.MCR-13-0411. Epub 2013 Dec 13.
Mol Cancer Res. 2014.
PMID: 24337067